Dr. Jeffrey Caleb Haynes, MD

Dr. Haynes practices at Rochester General Hospital in Rochester, New York, part of Rochester Regional Health.

Dr. Haynes' NPI, 1013073873, was assigned on December 28, 2006. Dr. Haynes graduated from Perelman School of Medicine - Philadelphia in 2004. Dr. Haynes holds New York license 252834-1.

Dr. Haynes' primary practice is Rochester General Hospital, at 1425 Portland Avenue, Rochester, NY 14621 in Monroe County. The practice phone is (585) 922-4000.

Dr. Haynes' primary practice is Rochester General Hospital in Rochester, New York, part of Rochester Regional Health. Dr. Haynes is also affiliated with United Memorial Medical Center. The medical group on file is United Memorial Medical Center. Dmand AI also links Dr. Haynes to 2 more hospitals and 5 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Haynes practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Haynes' primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Haynes is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Haynes' licenses on file in 2 states: New York and Pennsylvania.

Dmand AI lists bone cancer radiation, brain cancer radiation, breast cancer radiation, cancer radiation-upper GI, head & neck cancer radiation, lung cancer radiation, prostate cancer radiation and uterine cancer radiation among the conditions Dr. Haynes treats.

CMS data shows 179 Medicare services from Dr. Haynes across 8 procedure codes in 2024, for 63 Medicare patients. Medicare paid $16,535 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 63 Medicare patients who saw Dr. Haynes in 2024. The largest group is 65 to 74, with 31 patients. 75% of them have cancer, and 71% have high blood pressure. 19% are also on Medicaid. Their average risk score is 2.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Haynes' median patient age at 74, with 48% women.

In 2024, Dr. Haynes wrote 152 Medicare Part D claims for 63 patients. 97% of them were for generic drugs. CMS names the drug for 83 of them, across 3 drugs with 11 or more claims each, at $1,312 in total drug cost. In 2023, CMS named 97 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Haynes for performance year 2024, reported through an alternative payment model (APM). Dr. Haynes accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Haynes as offering telehealth.

Dmand AI links 1 paper to Dr. Haynes. Dr. Haynes' most frequent co-authors are David I. Rosenthal, MD and Randal S. Weber, MD.

CMS Open Payments shows 20 general payments to Dr. Haynes from 14 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 97% of the total. Siemens Medical Solutions USA, Inc. paid the most, $279.

Dr. Haynes graduated from Perelman School of Medicine - Philadelphia in 2004. Dr. Haynes is a member of ASCO.

Dr. Haynes is in network with 18 carriers, including Aetna, MVP Health Care and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.